Doctor Says J&J/Cordis Stents Infringe Patent

Law360 (October 10, 2007, 12:00 AM EDT) -- A doctor from New Jersey is suing Johnson & Johnson and subsidiary Cordis Corp. in a bid to tap into the multibillion-dollar market for drug-eluting coronary stents, claiming that the defendants' stents infringe a patent he secured in 1997.

Bruce N. Saffran, M.D., Ph.D., filed the lawsuit on Tuesday, asking an east Texas court to award treble damages and issue a permanent injunction barring the alleged infringement of the patent-in-suit.

J&J/Cordis and Boston Scientific Corp. are currently the only two companies with regulatory approval to market...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.